FDA approves RHA Redensity Eye for undereye hollowing

The FDA has approved RHA Redensity Eye, a specialized hyaluronic acid dermal filler, for the correction of moderate to severe volume loss and hollowing under the eyes, Revance and Teoxane announced in a press release.The formula, which is part of the Teoxane RHA Collection, is available for adults aged 22 years or older.

Raccontata dahealio.com